From the Departments of Neuroradiology (L.D., D.D., E.P., E.V., A.C., E.P.).
Neurology (G.C.R., A.K.-L.).
AJNR Am J Neuroradiol. 2019 Jul;40(7):1140-1148. doi: 10.3174/ajnr.A6096. Epub 2019 Jun 20.
Postgadolinium MR imaging is crucial for brain tumor diagnosis and morphometric assessment. We compared brain tumor enhancement visualization and the "target" object morphometry obtained with the most commonly used 3D MR imaging technique, MPRAGE, with 2 other routinely available techniques: sampling perfection with application-optimized contrasts by using different flip angle evolutions (SPACE) and volumetric interpolated brain examination (VIBE).
Fifty-four contrast-enhancing tumors (38 gliomas and 16 metastases) were assessed using MPRAGE, VIBE, and SPACE techniques randomly acquired after gadolinium-based contrast agent administration on a 3T scanner. Enhancement conspicuity was assessed quantitatively by calculating the contrast rate and contrast-to-noise ratio, and qualitatively, by consensus visual comparative ratings. The total enhancing tumor volume and between-sequence discrepancy in the margin delineation were assessed on the corresponding 3D target objects contoured with a computer-assisted software for neuronavigation. The Wilcoxon signed rank and Pearson χ nonparametric tests were used to investigate between-sequence discrepancies in the contrast rate, contrast-to-noise ratio, visual conspicuity ratings, tumor volume, and margin delineation estimates. Differences were also tested for 1D (Response Evaluation Criteria in Solid Tumors) and 2D (Response Assessment in Neuro-Oncology) measurements.
Compared with MPRAGE, both SPACE and VIBE obtained higher contrast rate, contrast-to-noise ratio, and visual conspicuity ratings in both gliomas and metastases ( range, <.001-.001). The between-sequence 3D target object margin discrepancy ranged between 3% and 19.9% of lesion tumor volume. Larger tumor volumes, 1D and 2D measurements were obtained with SPACE ( range, <.01-.007).
Superior conspicuity for brain tumor enhancement can be achieved using SPACE and VIBE techniques, compared with MPRAGE. Discrepancies were also detected when assessing target object size and morphology, with SPACE providing more accurate estimates.
钆对比后磁共振成像(MR)对脑肿瘤的诊断和形态计量评估至关重要。我们比较了最常用的 3D MR 成像技术——最大信号强度投影(MPRAGE)与另外两种常规技术——应用优化对比采样的各向同性容积加速采集(SPACE)和容积内插脑检查(VIBE)获取的脑肿瘤增强可视化和“目标”物体形态计量学。
在 3T 扫描仪上使用基于钆的造影剂后,随机采集 54 例增强肿瘤(38 例胶质瘤和 16 例转移瘤)的 MPRAGE、VIBE 和 SPACE 技术。通过计算对比率和对比噪声比进行定量评估,通过共识视觉比较评分进行定性评估。使用计算机辅助神经导航软件对相应的 3D 目标物体进行轮廓勾画,评估总增强肿瘤体积和序列间边界勾画差异。使用 Wilcoxon 符号秩和 Pearson χ 非参数检验研究对比率、对比噪声比、视觉显著性评分、肿瘤体积和边界勾画估计的序列间差异。还对 1D(实体瘤反应评价标准)和 2D(神经肿瘤反应评估)测量进行了差异测试。
与 MPRAGE 相比,SPACE 和 VIBE 在胶质瘤和转移瘤中均获得了更高的对比率、对比噪声比和视觉显著性评分(范围,<.001-.001)。序列间 3D 目标物体边界差异范围为病变肿瘤体积的 3%至 19.9%。SPACE 获得了更大的肿瘤体积、1D 和 2D 测量值(范围,<.01-.007)。
与 MPRAGE 相比,SPACE 和 VIBE 技术可获得更好的脑肿瘤增强可视化效果。在评估目标物体大小和形态时也发现了差异,SPACE 提供了更准确的估计。